Lupus follow-up study at Brest Hospital
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study follows people with systemic lupus erythematosus (an autoimmune disease) who are seen in a special clinic. It aims to track their health over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old
- You must be a patient in the lupus multidisciplinary clinic at Brest University Hospital
- You must agree to take part
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study focuses on people aged 18 and older with lupus who attend a multi-team clinic visit in Brest, France. It mainly looks at whether you can participate in the multidisciplinary consultation and its related study procedures.
This study looks at the long-term health of people with lupus. It aims to understand how the disease progresses over time.
This research study aims to better understand systemic lupus erythematosus (SLE), an autoimmune disease where the body's immune system attacks its own tissues. Researchers will evaluate patients with lupus, study genetic factors, and perform optional imaging tests to learn how the disease affects blood vessels and the heart.
This study looks at the health information and background of people with lupus in Egypt, using existing medical records from 2016 to 2023. It helps doctors understand lupus better, but it does not test a new treatment or medicine.
This study looks at a type of immune cell in patients with active lupus. It may help doctors understand how lupus affects the immune system and could lead to better treatments.
This research study collects samples and information from people with rheumatoid arthritis, lupus, or scleroderma, plus healthy volunteers, to better understand how the immune system works in these conditions. By comparing these groups, researchers hope to find new ways to treat and manage autoimmune diseases.
Hear when a new Systemic Lupus Erythematosus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.